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The recent discovery of leptin is poten-tially important for re s e a rch into obe-sity and related diseases (1). Leptin is
a hormone produced by the fat cells, and is
thought to play a key role in the control of
body weight (2,3). Leptin is hypothetically
involved in a feedback loop linking fat and
a satiety/energy expenditure center in the
hypothalamus. This feedback loop appears
to be disturbed in obesity (4,5). Obesity is
also often accompanied by disturbances in
blood pre s s u re or lipid metabolism re l a t e d
to insulin resistance (decreased tissue sen-
sitivity to insulin) (6,7). Recent studies sug-
gest a complex interrelationship between
leptin and insulin or insulin resistance (2).
Experimental studies in mice and rats show
that insulin affects leptin concentrations
(4) and that recombinant leptin influ e n c e s
insulin resistance and triglyceride metabo-
lism (8,9). Human studies confirm a re l a-
tionship between insulin and leptin
(10,11), but are controversial with re g a rd
to the involvement of leptin in insulin re s i s-
tance or triglyceride metabolism (3,12–16).
This controversy might partly be explained
by the selection of specific study popula-
tions or by small sample sizes. Another
explanation might be the role of leptin in a
feedback loop, which would diff e re n t i a t e
cause and effect. For example, some inves-
tigators have hypothesized that leptin has
an influence on insulin resistance (12), oth-
ers that insulin resistance has an influ -
ence on leptin (17). The purpose of the
p resent study was to gain insight into the 
regulation of leptin concentrations. We
t h e re f o re explored, in a large cro s s -
sectional population-based study, the 
i n fluence on serum leptin concentrations 
of potential determinants related to 
body adiposity, energy balance, and insu-
lin re s i s t a n c e .
RESEARCH DESIGN AND
M E T H O D S
Subjects
A random sample of 50- to 74-year-old sub-
jects was taken from the population re g i s t e r
of the town of Hoorn in the Netherlands
(57,000 inhabitants). Of the 3,553 subjects
invited, 2,540 (71.5%) participated, of whom
56 were excluded from the analyses because
they were non-Caucasian. Thus, the fin a l
c o h o rt consisted of 2,484 subjects (18). Sub-
jects who re p o rted having diabetes (n = 104)
w e re excluded from the present analyses to
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Leptin and Variables of Body Adiposity,
E n e rgy Balance, and Insulin Resistance in
a Population-Based Study
The Hoorn Study
O R I G I N A L  A R T I C L E
O B J E C T I V E — Leptin is thought to play a key role in the control of body weight. There is
a complex interrelationship between leptin and insulin or insulin resistance, but it is unknown
how leptin is regulated. We there f o re explored, in a large population-based study of 2,484 Cau-
casian subjects aged 50–74 years, the relationship between leptin and variables of body adi-
p o s i t y, energy balance, and insulin re s i s t a n c e .
RESEARCH DESIGN AND METHODS— Leptin was measured by means of a radioim-
m u n o a s s a y. Multiple linear re g ression analyses were perf o rmed with leptin as dependent vari-
able and age, sex, BMI, waist circ u m f e rence, daily energy intake, physical activity, smoking,
h y p e rtension, fasting triglyceride concentrations, HDL cholesterol, fasting plasma glucose, and
fasting plasma insulin concentrations as independent variables (determ i n a n t s ) .
R E S U LT S — Leptin concentrations were found to be four times higher in women than in
men. Effect modification between sex and potential determinants was expected, and the analy-
ses were perf o rmed separately for women and men. BMI was the strongest determinant of lep-
tin in women and waist circ u m f e rence the strongest determinant in men. BMI, waist
c i rc u m f e rence, insulin, and triglyceride concentrations were independently and signific a n t l y
(P , 0.05) associated with leptin, while inverse associations were shown for smoking and daily
e n e rgy intake (borderline signific a n c e ) .
C O N C L U S I O N S— This study confirms the relationship between insulin and leptin and, in
addition, suggests a relationship between triglyceride concentrations and leptin independent
of sex, BMI, waist circ u m f e rence, and insulin. 
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p revent any possible influence from blood
glucose–lowering treatment or diet. Sub-
jects with missing measurements of leptin
concentrations due to lost serum samples
w e re also excluded (n = 35).
Survey procedures
Detailed information on the Hoorn Study
population has already been published
(18). Participants underwent a 75-g oral
glucose tolerance test and were classifie d
a c c o rding to the 1985 World Health
O rganization criteria (19). Height, weight,
and waist and hip circ u m f e rence were
m e a s u red as described elsewhere (20) and
used to calculate BMI (kg/m2) and the
waist-to-hip ratio. Hypertension was
d e fined as current treatment with antihy-
p e rtensive drugs or an elevated blood pre s-
s u re (diastolic $95 mmHg or systolic
$160 mmHg). Physical activity was esti-
mated by asking nine equally weighted yes
or no questions about regular perf o rm a n c e
of the following activities: sport, cycling,
g a rdening, walking, doing odd jobs, going
up stairs at home, household activities,
daily food shopping, and working, whether
paid or unpaid. Daily energy intake (kilo-
calories) was measured by means of a self-
a d m i n i s t e red validated semiquantitative
f o o d - f requency questionnaire (21).
Laboratory analyses
Leptin was measured in banked seru m
samples. Detailed information on the
radioimmunoassay used to measure seru m
leptin concentrations (micrograms per
liter) has been published recently (22).
Fasting and 2-h plasma glucose concentra-
tions (millimoles per liter) were determ i n e d
a c c o rding to a glucose dehydro g e n a s e
method (Merck, Darmstadt, Germ a n y ) .
HDL cholesterol and triglycerides (mil-
limoles per liter) were measured by means
of enzymatic techniques (Boehringer
Mannheim, Mannheim, Germany). One
radioimmunoassay was used to measure
insulin (picomoles per liter), and had
,0.2% cro s s - reactivity with proinsulin and
d e s - 3 1 , 3 2 - p roinsulin (Linco Research, St.
Louis, MO). A second radioimmunoassay
was also used to measure insulin, and had
±80% cro s s - reactivity with proinsulin and
d e s - 3 1 , 3 2 - p roinsulin (Novo Nord i s k ,
Copenhagen, Denmark). The latter meas-
u rement was used to calculate insulin re s i s-
tance by the homeostasis model assessment
(HOMA) method because it is thought to
be more similar to the assay of the HOMA
method validation study (23).
Calculation of insulin resistance
Insulin resistance was calculated by the
HOMA method, using fasting plasma glu-
cose and insulin concentrations (23).
Assuming that normal-weight norm a l
subjects ,35 years of age have an insulin
resistance of 1, the value for insulin re s i s-
tance can be assessed by the formula: fast-
ing insulin (µU/ml) 3 fasting glucose
(mmol/l) / 22.5 (23). Results from HOMA
c o rrelate well with measurements obtained
by means of the euglycemic clamp tech-
nique, as was shown in the HOMA method
validation study (23) and by a separate
study in 16 subjects ( J.B.R., J.M.D., C.
Popp-Snijders, P.J.K., G.N., C.D.A.S.,
L.M.B., R.J.H., unpublished observ a t i o n s ) .
Statistical analysis
A first impression of relationships of leptin
was provided by graphs and Spearm a n ’s
rank correlation coefficients. Subsequently,
multiple linear re g ression models were con-
s t ructed to explore in detail the re l a t i o n s h i p
between serum leptin concentrations and
d e t e rminants related to body adiposity,
e n e rgy balance, and insulin re s i s t a n c e .
E ffect modification was expected to occur
between sex and potential determinants, so
the analyses were perf o rmed separately for
women and men (1). The associations
between leptin and potential determ i n a n t s
e x p l o red in the first models were adjusted
for age; in the subsequent models, they
w e re adjusted for age and BMI; and in a
final model, they were adjusted for age,
BMI, and each other. The distribution of
leptin was normalized by transform a t i o n
into its natural logarithm to improve the
plots of residual analyses. Results are
e x p ressed as percentage diff e rences in
s e rum leptin concentrations associated with
the interq u a rtile range of potential determ i-
nants (in the final model, 95% CIs are also
p rovided). A zero within the 95% CI
implies that no independent statistically
s i g n i ficant (P , 0.05) association could be
established. The pro p o rtion of variation in
leptin (R2) explained by a potential deter-
minant in the final model is also pro v i d e d .
All data were analyzed with an SPSS-PC
s o f t w a re package (SPSS, Chicago).
R E S U LT S — Medians and interq u a rt i l e
ranges of serum leptin concentrations were
four times higher in women, 14.4 µg/l
(8.2–23.7), than in men, 3.4 µg/l (1.9–5.8).
Characteristics of determinants related to
body adiposity, energy balance, and insulin
resistance of the study population were
s t r a t i fied for sex, and are shown in Table 1.
The correlation between leptin and BMI,
fasting plasma insulin, calculated insulin
resistance, and triglycerides is shown in
Table 1—Clinical and biochemical characteristics of study population stratified for sex
Women Men
n 1 , 2 5 4 1 , 0 9 1
Leptin (µg/l) 14.4 (8.2–23.7) 3.4 (1.9–5.8)
Age (years) 61 (55–68) 60 (55–67)
Variables related to body adiposity
BMI (kg/m2) 26.3 (24.0–29.1) 26.0 (24.2–27.8)
Waist (m) 0.86 (0.79–0.94) 0.95 (0.89–1.00)
Waist-to-hip ratio 0.84 (0.79–0.89) 0.95 (0.91–0.99)
Variables related to energy balance
Daily energy intake (kcal 3 1 , 0 0 0 ) 1.8 (1.5–2.1) 2.3 (1.9–2.7)
Physical activities (n) 6 (4–7) 6 (5–7)
C u rrent smoking (% yes) 2 8 3 6
Variables related to insulin re s i s t a n c e
Fasting plasma glucose (mmol/l) 5.3 (5.0–5.8) 5.5 (5.2–5.9)
2-h plasma glucose (mmol/l) 5.6 (4.7–6.8) 5.4 (4.3–6.6)
Fasting specific insulin (pmol/l) 76 (60–99) 77 (61–101)
Fasting nonspecific insulin (pmol/l) 84 (61–123) 90 (65–124)
Calculated insulin resistance (HOMA) 3.3 (2.3–5.2) 3.7 (2.6–5.3)
Triglycerides (mmol/l) 1.3 (1.0–1.8) 1.4 (1.1–2.0)
HDL cholesterol (mmol/l) 1.4 (1.2–1.7) 1.1 (1.0–1.4)
H y p e rtension (% yes) 3 1 3 0
Data are medians (interq u a rtile range), unless otherwise indicated. Scale of physical activities: 1–9; 1 = low, 
9 = high.
Figs. 1–4. BMI was the strongest determ i-
nant of leptin in women, and waist cir-
c u m f e rence was the strongest determ i n a n t
in men, as can be seen in Tables 2 and 3,
re s p e c t i v e l y. However, to study associations
that are independent of body fat mass,
adjustments were made for BMI in both
women and men (Tables 2 and 3). The
s t rong influence of BMI on the association
of determinants related to energy balance
and insulin resistance suggests that body
adiposity may, at least part i a l l y, play an
i n t e rmediate ro l e .
Daily energy intake and physical activ-
ity were inversely associated with leptin.
The association with daily energy intake
was statistically of borderline significance 
(P = 0.07) in women and significant (P ,
0.05) in men (Tables 4 and 5, re s p e c t i v e l y ) .
Smoking was inversely associated with lep-
tin in both sexes, after adjustment for deter-
minants related to body adiposity, energ y
balance, and insulin resistance (Tables 2–5).
All re g ression models showed an inde-
pendent association between fasting triglyc-
eride concentrations and leptin (Tables 2–5).
Thus, in both sexes, triglyceride concentra-
tions were positively associated with leptin,
independent of BMI, waist circ u m f e re n c e ,
and insulin. The re g ression models used for
Tables 4 and 5 suggested that the re l a t i o n-
ships between triglyceride and leptin and
between insulin and leptin are of the same
magnitude. Individuals at the 75th per-
centile had 5–10% higher serum leptin con-
centrations compared with those at the 25th
p e rcentile of triglyceride and insulin distri-
bution, after adjustment for BMI and waist
c i rc u m f e rence (Tables 4 and 5). Calculated
insulin resistance was associated with leptin
in such a way that insulin-resistant subjects
had high serum leptin concentrations. In the
same way, fasting plasma insulin concentra-
tions were associated with leptin. One
re g ression model with ln(leptin) as depen-
dent variable that included both insulin and
insulin resistance suggested weakly inde-
pendent associations for both determ i n a n t s
in men only (data not shown). Applying cal-
culated insulin resistance instead of insulin
and fasting glucose in the models shown in
Tables 4 and 5 resulted in similar coeff i c i e n t s
for the remaining determinants (data not
shown). In women, fasting plasma glucose
was inversely associated with leptin, after
adjustment for determinants related to body
adiposity and insulin resistance (Table 4).
Results did not essentially change when 2-h
plasma glucose was included in the model
instead of fasting plasma glucose (data not
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F i g u re 1—C o rrelation between leptin and BMI in a 50- to 74-year-old general Dutch population: 0.68
for women ( ) (P , 0.001) and 0.59 for men ( ) (P , 0.001).
F i g u re 2—C o rrelation between leptin and fasting plasma insulin in a 50- to 74-year-old general Dutch
population: 0.47 for women ( ) (P , 0.001) and 0.53 for men ( ) (P , 0.001).
shown). Apart from diff e rences between the
sexes with re g a rd to associations of body adi-
posity and leptin, hypertension and HDL
c h o l e s t e rol were positively associated with
leptin in men only, after adjustment for
d e t e rminants related to body adiposity and
insulin resistance (Table 5).
To estimate the possible residual influ-
ence of the amount of body adiposity on
the final conclusions, an alternative strategy
was implemented. A re f e rence range of
s e rum leptin concentrations, based on BMI
and sex, was used to create categories of
individuals according to leptin concentra-
tions: below the 5th percentile, between the
5th and the 95th percentiles, and above the
95th percentile (1). The same determ i n a n t s
of leptin as those mentioned in Table 1
w e re compared in the three categories. The
results were essentially the same, and were
t h e re f o re omitted from the present paper.
C O N C L U S I O N S — The present larg e
c ross-sectional population-based study
suggests that various determinants re l a t e d
to body adiposity, energy balance, and
insulin resistance are involved in the re g u-
lation of serum leptin concentrations.
Body adiposity may play an interm e d i-
ate role. Various studies have shown that
body adiposity is the major determinant of
leptin (24,25). We wanted to study the
association of leptin with determ i n a n t s
related to energy balance and insulin re s i s-
tance, independent of body adiposity. How-
e v e r, accurate methods to estimate body
a d i p o s i t y, such as hydro d e n s i t o m e t ry, were
not feasible in the present study. Adjustment
for body adiposity was, there f o re, imperf e c t ,
and residual confounding cannot be
excluded. Nevertheless, the final conclu-
sions of the present study were support e d
by similar results when an alternative strat-
egy based on a leptin re f e rence line (1) was
used to adjust for body adiposity.
Body adiposity has also been sug-
gested to be the main contributor to the
d i ff e rence of serum leptin concentrations
between the sexes (24,25). Both sex and
d e t e rminants related to body adiposity
a p p e a red to be modifiers of serum leptin
concentrations. BMI appeared to be the
s t rongest determinant of leptin in women,
and waist circ u m f e rence the stro n g e s t
d e t e rminant in men. In the Rancho
B e rn a rdo Heart Study, waist circ u m f e r-
ence appeared to be a better anthro p o-
metric estimate of obesity and fat
distribution than the waist-to-hip ratio
(26). The contribution of body adiposity
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Figure 3—Correlation between leptin and calculated insulin resistance in a 50- to 74-year-old gen -
eral Dutch population: 0.46 for women ( ) (P , 0.001) and 0.52 for men ( )(P , 0.001).
Figure 4—Correlation between leptin and triglycerides in a 50- to 74-year-old general Dutch popu -
lation: 0.32 for women ( ) (P , 0.001) and 0.28 for men ( ) (P , 0.001).
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to serum leptin concentrations could fur-
ther depend on its location. Subcutaneous
and visceral adiposity are supposed to
contribute diff e rently (27,28). In addition,
a n d rogens may have affected the diff e r-
ence in serum leptin concentrations
between the sexes (25).
Smoking was independently and
inversely associated with serum leptin
concentrations in both men and women,
which is in line with an existing re p o rt
that suggested that smoking may mod-
ify the sensitivity of hypothalamic lep-
tin receptors and, consequently, mod-
ulate leptin synthesis and reduce body
weight (29).
Mechanisms underlying the associa-
tion between serum triglyceride and leptin
concentrations are unclear. Serum triglyc-
eride concentrations may lead to expansion
of the volume of fat cells, which, in turn ,
Table 2—P e rcentage diff e rence in serum leptin concentrations associated with a change from the 25th to the 75th percentile of potential determ i n a n t s
of leptin in women
Linear re g ression models with ln(leptin) as dependent variable
Adjusted for age Adjusted for age and BMI
Potential determinants (IQR) % Diff e rence in leptin R2 model (%) % Diff e rence in leptin R2 model (%)
Age (12.5 years) 2 0 1 . 8* — —
BMI (5.1 kg/m2) 1 0 1 4 1 . 7* — —
Waist circ u m f e rence (0.15 m) 6 7 3 5 . 8* 2 9 1 . 5*
Waist-to-hip ratio (0.10) 4 8 1 1 . 2* 8 0 . 3*
Daily energy intake (0.6 kcal 3 1 , 0 0 0 ) 27 0 . 5* 23 —
Physical activities (3) 21 7 1 . 4* 23 —
C u rrent smoking (yes vs. no) 22 4 2 . 1* 21 4 0 . 7*
Fasting plasma glucose (0.8 mmol/l) 8 1 . 4* — —
2-h plasma glucose value (2.1 mmol/l) 9 1 . 7* 2 —
Fasting specific insulin (39 pmol/l) 2 3 8 . 7* 8 0 . 7*
Fasting nonspecific insulin (62 pmol/l) 3 9 1 5 . 4* 1 5 1 . 9*
Calculated insulin resistance (2.9) 2 8 1 1 . 4* 8 0 . 8*
Triglycerides (0.8 mmol/l) 2 3 5 . 5* 8 0 . 7*
HDL cholesterol (0.5 mmol/l) 21 9 3 . 4* 23 —
H y p e rtension (yes vs. no) 3 6 2 . 8* 6 —
Data for current smoking and hypertension re p resent the percentage diff e rence in serum leptin concentration associated with yes vs. no. Scale of physical activities: 1–9;
1 = low; 9 = high. R2 is the pro p o rtion of the variation in leptin (ln) explained by the potential determinant in the left margin (%). IQR; interq u a rtile range or a change
f rom the 25th to the 75th percentile. *P , 0.01. 
Table 3—P e rcentage diff e rence in serum leptin concentrations associated with a change from the 25th to the 75th percentile of potential determ i n a n t s
of leptin in men
Linear re g ression models with ln(leptin) as dependent variable
Adjusted for age Adjusted for age and BMI
Potential determinants (IQR) % Diff e rence in leptin R2 model (%) % Diff e rence in leptin R2 model (%)
Age (12 years) 2 3 1 . 9* — —
BMI (3.6 kg/m2) 9 4 3 6 . 3* — —
Waist circ u m f e rence (0.11 m) 1 0 6 4 2 . 3* 7 0 7 . 3*
Waist-to-hip ratio (0.11) 8 4 2 6 . 6* 3 5 4 . 5*
Daily energy intake (0.8 kcal 3 1 , 0 0 0 ) 21 1 1 . 0* 29 0 . 6*
Physical activities (2) 21 2 1 . 5* 28 0 . 6*
C u rrent smoking (yes vs. no) 22 6 2 . 5* 28 0 . 2
Fasting plasma glucose (0.7 mmol/l) 1 1 3 . 0* 2 —
2-h plasma glucose value (2.3 mmol/l) 2 1 6 . 8* 9 1 . 2*
Fasting specific insulin (40 pmol/l) 2 2 9 . 5* 1 0 2 . 4*
Fasting nonspecific insulin (59 pmol/l) 5 0 2 0 . 9* 2 3 4 . 9*
Calculated insulin resistance (2.7) 3 2 1 5 . 7* 1 4 3 . 1*
Triglycerides (0.9 mmol/l) 2 6 7 . 3* 1 1 1 . 4*
HDL cholesterol (0.5 mmol/l) 21 3 1 . 3* — —
H y p e rtension (yes vs. no) 5 4 4 . 6* 2 5 1 . 2*
Data for current smoking and hypertension re p resent the percentage diff e rence in serum leptin concentration associated with yes vs. no. Scale of physical activities: 1–9;
1 = low; 9 = high. R2 is the pro p o rtion of the variation in leptin (ln) explained by the potential determinant in the left margin (%). IQR; interq u a rtile range or a change
f rom the 25th to the 75th percentile. *P , 0.01. 
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may lead to an increase in o b gene expre s-
sion and serum leptin concentrations. It is
also possible that serum triglyceride con-
centrations are affected by leptin, e.g., by
i n d i rect mechanisms involved in insulin
resistance (8,9). A recent study in rats
re p o rted a triglyceride-lowering effect of
leptin (9), and a study in mice re p o rted an
attenuating effect of leptin on the lipogenic
e ffect of insulin in skeletal muscle (8).
Skeletal muscle triglyceride concentrations
have been shown to be related to insulin
resistance in humans (30). Studies in
humans on the relationship between
triglyceride concentrations and leptin have
so far re p o rted controversial observ a t i o n s .
A p a rt from the present study, two other
studies found an association of triglycerides
with leptin in men after adjustment for
p e rcentage body fat assessed by skinfold
m e a s u rements (3) or after adjustment for
BMI and insulin sensitivity (12). One study
in humans found no association between
triglycerides and leptin after adjustment
for body fat mass estimated according to
the hydrostatic weighing technique (16).
H o w e v e r, that particular study also failed to
demonstrate an independent association
between insulin and leptin in men, and
methodological shortcomings in that study
a re there f o re also plausible.
The relationship between insulin and
leptin, which was also found in this study,
is in concordance with re p o rted findings in
humans showing an induction of o b g e n e
e x p ression and an increase in leptin con-
centrations by insulin infusion, possibly
due to the trophic effect of insulin on
adipocytes (10,31,32). In this study, an
association between insulin resistance and
leptin was found that was limited in pre c i-
sion because the HOMA method was used
to calculate insulin resistance (23). Never-
theless, an association between insulin
resistance and leptin remains a highly
intriguing finding, since insulin re s i s t a n c e
was proposed as an adaptation for weight
maintenance many years before the dis-
c o v e ry of leptin (33). The recent literature
is controversial with re g a rd to the re l a t i o n-
ship between insulin resistance and leptin.
A number of studies have re p o rted associ-
ations between insulin resistance and lep-
tin in normal glucose-tolerant subjects (13,
14,34), but one did not (35). Other stud-
ies re p o rted no association between insulin
resistance and leptin in subjects with dia-
betes (15,36). The findings are in line with
the possibility of hyperinsulinemia induc-
ing hyperleptinemia and leptin re s i s t a n c e
(15) or, altern a t i v e l y, of leptin inducing
insulin resistance, which, in turn, causes
hyperinsulinemia. Downregulation of lep-
tin transport in the brain (5) may result in
reduced cere b rospinal fluid leptin concen-
trations, despite increased serum leptin
concentrations. Reduced cere b ro s p i n a l
fluid leptin concentrations are assumed to
p romote an increase in food ingestion, an
i n c rease in adiposity mass, and, subse-
q u e n t l y, an increase in insulin re s i s t a n c e
(37). We also found that hypertension and
HDL cholesterol were independently asso-
ciated with leptin in men and that fasting
plasma glucose was independently associ-
ated with leptin in women. A study in
We s t e rn Samoa found an association
between diastolic blood pre s s u re and lep-
tin in men, but no relationship between
HDL cholesterol and leptin (12). Another
study involving a Canadian Aboriginal
population found an independent and
inverse association of glucose tolerance
status with leptin levels in women (38),
which was confirmed by the present study.
A possible indirect relationship between
Table 4—P e rcentage diff e rence in serum leptin concentrations associated with a change from the
25th to the 75th percentile of potential determinants of leptin in women, using a single linear
re g ression model (R2 = 47%)
Potential determinant (IQR) % Diff e rence in leptin (95% CI)
C o n s t a n t 260 (278 to 23 1 )
Age (12.5 years) 23 (29 to 3)
BMI (5.1 kg/m2) 62 (49 to 75)
Waist circ u m f e rence (0.15 m) 25 (15 to 37)
Daily energy intake (0.6 kcal 3 1 , 0 0 0 ) 24 (28 to 0)
Physical activities (3) 24 (211 to 3)
C u rrent smoking (yes vs. no) 218 (224 to 21 1 )
Fasting plasma glucose (0.8 mmol/l) 23 (26 to 0)
Fasting specific insulin (39 pmol/l) 6 (3 to 10)
Triglycerides (0.8 mmol/l) 7 (2 to 11)
HDL cholesterol (0.5 mmol/l) 2 (23 to 8)
H y p e rtension (yes vs. no) 2 (26 to 10)
Data for current smoking and hypertension re p resent the percentage diff e rence in serum leptin concentration
associated with yes vs. no. Scale of physical activities: 1–9; 1 = low, 9 = high. R2 is the pro p o rtion of the varia-
tion in leptin (ln) explained by the complete model. IQR, interq u a rtile range or a change from the 25th to the
75th perc e n t i l e .
Table 5—P e rcentage diff e rence in serum leptin concentrations associated with a change fro m
the 25th to the 75th percentile of potential determinants of leptin in men, using a single linear
re g ression model (R2 = 49%)
Potential determinant (IQR) % Diff e rence in leptin (95% CI)
C o n s t a n t 299 (2100 to 29 8 )
Age (12 years) 5 (23 to 13)
BMI (3.6 kg/m2) 35 (19 to 53)
Waist circ u m f e rence (0.11 m) 90 (68 to 114)
Daily energy intake (0.8 kcal 3 1 , 0 0 0 ) 26 (210 to 22 )
Physical activities (2) –8 (214 to 0)
C u rrent smoking (yes vs. no) 212 (219 to 23 )
Fasting plasma glucose (0.7 mmol/l) 22 (26 to 1)
Fasting specific insulin (40 pmol/l) 7 (3 to 10)
Triglycerides (0.9 mmol/l) 9 (5 to 14)
HDL cholesterol (0.5 mmol/l) 8 (1 to 16)
H y p e rtension (yes vs. no) 12 (2 to 23)
Data for current smoking and hypertension re p resent the percentage diff e rence in serum leptin concentration
associated with yes vs. no. Scale of physical activities: 1–9; 1 = low, 9 = high. R2 is the pro p o rtion of the varia-
tion in leptin (ln) explained by the complete model. IQR, interq u a rtile range or a change from the 25th to the
75th perc e n t i l e .
regulators of the glucose metabolism and
leptin seems there f o re possible, despite
negative results of former studies (34,39).
F u t u re studies in humans are warranted to
c o n firm these findings. Diff e rences in asso-
ciations between the sexes may be
explained by resistance to leptin, which is
assumed to be more prominent in women,
since the absolute serum leptin concentra-
tions are four times higher in women than
in men (25).
In conclusion, determinants related to
body adiposity, energy balance, and insulin
resistance are associated with serum leptin
concentrations. BMI and waist circ u m f e r-
ence are positively associated, where a s
physical activity (only in men), daily energ y
intake, and smoking are negatively associ-
ated with serum leptin concentrations. The
relationship between leptin and lipid and
glucose metabolism remains complex.
Triglyceride concentrations and insulin are
positively associated with leptin, indepen-
dent of BMI, waist circ u m f e rence, and each
o t h e r. Hypertension and HDL cholestero l
a re positively associated with leptin in men,
and fasting plasma glucose is negatively
associated with leptin in women, indepen-
dent of BMI, waist circ u m f e rence, and
insulin and triglyceride concentrations.
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